APA (7th ed.) Citation

E, C., W, T., SD, S., CH, C., Q, L., J, Z., . . . JO, L. (2025). Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure Prophylaxis. Journal of medicinal chemistry, 68(20), 21072. https://doi.org/10.1021/acs.jmedchem.5c01625

Chicago Style (17th ed.) Citation

E, Canales, et al. "Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure Prophylaxis." Journal of Medicinal Chemistry 68, no. 20 (2025): 21072. https://doi.org/10.1021/acs.jmedchem.5c01625.

MLA (9th ed.) Citation

E, Canales, et al. "Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure Prophylaxis." Journal of Medicinal Chemistry, vol. 68, no. 20, 2025, p. 21072, https://doi.org/10.1021/acs.jmedchem.5c01625.